A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value.
Natacha Entz-WerléLaetitia PoidevinPetr V NazarovOlivier PochBenoit LhermitteMarie Pierre ChenardHélène BurckelAmelia-Naomie SaboQuentin FuchsDavid CastelGeorges NoelLaurence ChoulierMonique DontenwillEric Van DyckPublished in: Cancers (2021)
We provide evidence that PARP1 overexpression, associated to XRCC1 expression, TP53 mutations, and TOP2A amplification, is a new theranostic and potential therapeutic target.